DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Anadrol (Oxymetholone) - Indications and Dosage

 
 



INDICATIONS AND USAGE

ANADROL®-50 Tablets is indicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond.

ANADROL®-50 Tablets should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids.

DOSAGE AND ADMINISTRATION

The recommended daily dose in children and adults is 1-5 mg/kg body weight per day. The usual effective dose is 1-2 mg/kg/day but higher doses may be required, and the dose should be individualized. Response is not often immediate, and a minimum trial of three to six months should be given. Following remission, some patients may be maintained without the drug; others may be maintained on an established lower daily dosage. A continued maintenance dose is usually necessary in patients with congenital aplastic anemia.

HOW SUPPLIED

ANADROL®-50 (oxymetholone) Tablets is supplied in bottles of 100 (NDC 68220-055-10) white scored tablets embossed with 0055 and ALAVEN. Keep out of reach of children. Dispense in a tight, light resistant container.

STORAGE

Store at controlled room temperature 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP].

Rx Only
Manufactured for:
ALAVEN Pharmaceutical
Marietta, GA 30067
Anadrol®-50 is a registered trademark of Alaven™ Pharmaceutical
Address medical inquries to:
Alaven Pharmaceutical LLC
2260 Northwest Parkway, Suite A
Marietta, GA 30067
or call toll free
1-888-317-0001

ALAVEN™ PHARMACEUTICAL
055 Rev 12/06
© 2006 ALAVEN Pharmaceutical

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012